Universal Coronavirus Vaccine Completes Phase 1 as Drug Discovery AI Scales Up

AI tools are reshaping how vaccines and drugs are designed, tested, and approved — a landmark week for medicine's digital transformation.

• AI-Designed Universal Coronavirus Vaccine Completes First Human Trial
• $1.8 Billion Pledged for Open AI Biology Datasets to Predict and Treat Disease
• AI Virtual Trials Predicted Drug Failures Before They Happened — and Ethics Questions Follow
• Danaher to Open AI-Robotic Autonomous Laboratory for Antibody Discovery by Early 2027
• BullFrog AI Identifies Novel Depression Targets in Partnership with Major Pharma
• Thermo Fisher's AI Cuts Clinical Trial Consent Form Drafting Time by Half